24-Week Naturalistic Observational Study of Efficacy of Quetiapine in Patients With Schizophrenia or Schizoaffective Disorder

AstraZeneca1 个研究点分布在 1 个国家目标入组 1,000 人开始时间: 2007年5月最近更新: 2008年10月6日

适应症

试验速览

To assess the efficacy of 24-week treatment with quetiapine in patients with schizophrenia or schizoaffective disorder

•The patient and the patient's legal representative (if any) must understand the nature of the study and must have given written consent
•The patient suffers from schizophrenia or schizoaffective disorder according to DSM-IV-TR
•The patient is between 18 and 65 years old(extremes included)
•On the basis of physical and neurological examination, medical history, the patient is, in the investigator's opinion, otherwise healthy
•If the subject is a female of childbearing potential, she must be not pregnant or breast-feeding and be using a reliable method of contraception. Reliable methods may include abstinence, hormonal contraceptives (eg,oral contraceptives or long-term injectable or implantable hormonal contraceptives), double-barrier methods (eg, condom and diaphragm, condom and foam, condom and sponge), intrauterine devices, and tubal ligation

发起方

申办方类型

Industry

Loading locations...